Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|January 1, 1988
Monocyte defect causes decreased autoMLR in multiple sclerosis patientsC N Baxevanis, G J Reclos, P Arsenis, et al.Journal of Neuroimmunology|May 1, 1989
Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosisC N Baxevanis, G J Reclos, P Arsenis, et al.Immunopharmacology and Immunotoxicology|May 1, 1994
On the role of monokines in the generation of nonspecific suppressor T cell activity in vitroC N Baxevanis, G V Dedousis, A D Gritzapis, et al.Cancer Genetics and Cytogenetics|July 1, 1989
Mixed lineage leukemia with cytogenetically unrelated abnormal clonesG Bardi, N Pandis, P Arsenis, et al.Immunopharmacology and Immunotoxicology|January 1, 1990
Enhancement of human T lymphocyte function by prothymosin alpha: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytesC N Baxevanis, S Frillingos, K Seferiadis, et al.Immunopharmacology and Immunotoxicology|January 1, 1988
Mechanism of action of prothymosin alpha in the human autologous mixed lymphocyte responseC N Baxevanis, G J Reclos, M Economou, et al.Journal of Neuroimmunology|March 1, 1989
Peptides of myelin basic protein stimulate T lymphocytes from patients with multiple sclerosisC N Baxevanis, G J Reclos, C Servis, et al.Natural Immunity|January 1, 1993
Comparison of immune parameters in patients with one or two primary malignant neoplasmsC N Baxevanis, G J Reclos, A D Gritzapis, et al.Immunopharmacology and Immunotoxicology|September 15, 1998
Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicityC N Baxevanis, I F Voutsas, M H Soler, et al.Pageof 1